Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSTT01001 is a ligand of mitoNEET, a mitochondrial outer membrane protein.1 It binds to mitoNEET but does not activate peroxisome proliferator-activated receptor γ (PPARγ) in cell-free assays. TT01001 (100 mg/kg, p.o.) reduces skeletal muscle mitochondrial complex II-III activity and decreases plasma free fatty acids and blood glucose levels but does not increase body weight in a db/db mouse model of diabetes. It also inhibits monoamine oxidase B (MAO-B; IC50 = 8.84 µM).2
WARNING This product is not for human or veterinary use.
1. A novel MitoNEET ligand, TT01001, improves diabetes and ameliorates mitochondrial function in db/db mice. J. Pharmacol. Exp. Ther. 352(2), 338-345 (2015).
2. Synthesis and evaluation of enzyme inhibition by novel TT01001 derivatives as monoamine oxidase B inhibitors. Bioorg. Med. Chem. Lett. 117, 130045 (2025).